In lupus the CAR-T cells are modified not to target cancer, but instead a different type of immune cell called the B cell.

Covenant Health has announced the launch of CAR T-cell therapy at the Joe Arrington Cancer Research & Treatment Center (JACC) ...

Source Reference: Li C-H, et al "Long-term outcomes of GD2-directed CAR-T cell therapy in patients with neuroblastoma" Nat Med 2025; DOI: 10.1038/s41591-025-03513-0.

3. Infusion When you are ready, you will receive your personalized CAR T cells in one infusion. The process usually takes about an hour. From there, the CAR T cells may expand and travel throughout ...

Covenant Health is now offering CAR T-cell therapy at the Joe Arrington Cancer Research & Treatment Center, marking a major ...

In this study, 40% of patients received axi-cel, 30% received liso-cel, and 25% received tisa-cel. Overall, patients remained persistently immunosuppressed after infusion, with 48.1% having CD4+ T ...

In a small trial, CAR T-cells were infused following lymphodepletion therapy in patients with refractory lupus nephritis.

Despite the challenges and slow progress, some “promising results” have begun to emerge in the solid tumor, CAR T-cell space, Hinrichs said. A recent phase 1-2 study, for instance, found that ...

The list price is £297,000 per single infusion, which includes shipping, engineering, and generation of the CAR-T cells. Liso-cel is recommended only if provided under this commercial agreement.